Radio Taiwan International
Date: 30 September, 2020
By: Katherine Wei

Taipei-based Medigen Vaccine Biologics Corp. (MVC) will soon begin working with National Taiwan University Hospital on rolling out human trials for a COVID-19 vaccine.

Taipei-based Medigen Vaccine Biologics Corp. (MVC) will soon begin working with National Taiwan University Hospital on rolling out human trials for a COVID-19 vaccine. That was the word from the Food and Drug Administration on Wednesday. 

MVC’s vaccine had first been cleared for human trials at the end of August, with health authorities giving conditional approval. The condition for approval is that Medigen submits additional technical data on the vaccine.     [FULL  sTORY]